Diphtheria toxin mutant CRM197 is an inhibitor of protein synthesis that induces cellular toxicity

Toxicon

Volumn 51, Issue 3, 2008, Pages 473-477

  Qiao, Jian ^a   Ghani, Karim ^a   Caruso, Manuel ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

ADP rybosylation; CRM197; Diphtheria toxin; Elongation factor 2

Indexed keywords

ADENOSINE DIPHOSPHATE; DIPHTHERIA TOXOID CRM197; ELONGATION FACTOR 2;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CYTOTOXICITY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 39049150822     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2007.09.010     Document Type: Article

References (23)

1. Buzzi S., Rubboli D., Buzzi G., Buzzi A.M., Morisi C., and Pironi F. CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients. Cancer Immunol. Immunother. 53 (2004) 1041-1048
2. Collier R.J. Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century. Toxicon 39 (2001) 1793-1803
3. Foley B.T., Moehring J.M., and Moehring T.J. Mutations in the elongation factor 2 gene which confer resistance to diphtheria toxin and Pseudomonas exotoxin A. Genetic and biochemical analyses. J. Biol. Chem. 270 (1995) 23218-23225
4. Giannini G., Rappuoli R., and Ratti G. The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197. Nucleic Acids Res. 12 (1984) 4063-4069
5. Honjo T., Nishizuka Y., and Hayaishi O. Diphtheria toxin-dependent adenosine diphosphate ribosylation of aminoacyl transferase II and inhibition of protein synthesis. J. Biol. Chem. 243 (1968) 3553-3555
6. Johnson V.G., and Nicholls P.J. Histidine 21 does not play a major role in diphtheria toxin catalysis. J. Biol. Chem. 269 (1994) 4349-4354
7. Kageyama T., Ohishi M., Miyamoto S., Mizushima H., Iwamoto R., and Mekada E. Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity. J. Biochem. (Tokyo) 142 (2007) 95-104
8. Kimura Y., Saito M., Kimata Y., and Kohno K. Transgenic mice expressing a fully nontoxic diphtheria toxin mutant, not CRM197 mutant, acquire immune tolerance against diphtheria toxin. J. Biochem. (Tokyo) 142 (2007) 105-112
9. Maxwell I.H., Maxwell F., and Glode L.M. Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: possible strategy for inducing cancer cell suicide. Cancer Res. 46 (1986) 4660-4664
10. Miller A.D., Garcia J.V., von Suhr N., Lynch C.M., Wilson C., and Eiden M.V. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65 (1991) 2220-2224
11. Mitamura T., Higashiyama S., Taniguchi N., Klagsbrun M., and Mekada E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J. Biol. Chem. 270 (1995) 1015-1019
12. Miyamoto S., Hirata M., Yamazaki A., Kageyama T., Hasuwa H., Mizushima H., Tanaka Y., Yagi H., Sonoda K., Kai M., Kanoh H., Nakano H., and Mekada E. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res. 64 (2004) 5720-5727
13. Miyamoto S., Yagi H., Yotsumoto F., Kawarabayashi T., and Mekada E. Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. Cancer Sci. 97 (2006) 341-347
14. Moehring J.M., and Moehring T.J. Characterization of the diphtheria toxin-resistance system in Chinese hamster ovary cells. Somatic Cell Genet. 5 (1979) 453-468
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
16. Naglich J.G., and Eidels L. Isolation of diphtheria toxin-sensitive mouse cells from a toxin-resistant population transfected with monkey DNA. Proc. Natl. Acad. Sci. USA 87 (1990) 7250-7254
17. Naglich J.G., Metherall J.E., Russell D.W., and Eidels L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 69 (1992) 1051-1061
18. Pathak V.K., and Temin H.M. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc. Natl. Acad. Sci. USA 87 (1990) 6024-6028
19. Qiao J., and Caruso M. PG13 packaging cells produce recombinant retroviruses carrying a diphtheria toxin mutant which kills cancer cells. J. Virol. 76 (2002) 7343-7348
20. Qiao J., Black E.M., and Caruso M. Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant. Hum. Gene Ther. 11 (2000) 1569-1576
21. Qiao J., Roy V., Girard M.H., and Caruso M. High translation efficiency is mediated by the encephalomyocarditis virus internal ribosomal entry sites if the natural sequence surrounding the eleventh AUG is retained. Hum. Gene Ther. 13 (2002) 881-887
22. Raab G., and Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta 1333 (1997) F179-F199
23. Uchida T., Pappenheimer Jr. A.M., and Greany R. Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin. J. Biol. Chem. 248 (1973) 3838-3844